MEDIOS AG (ILM1.DE) Fundamental Analysis & Valuation

FRA:ILM1 • DE000A1MMCC8

16.3 EUR
+0.24 (+1.49%)
Last: Mar 4, 2026, 05:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ILM1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ILM1. ILM1 was compared to 30 industry peers in the Health Care Providers & Services industry. ILM1 has a great financial health rating, but its profitability evaluates not so good. ILM1 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. ILM1.DE Profitability Analysis

1.1 Basic Checks

  • ILM1 had positive earnings in the past year.
  • In the past year ILM1 had a positive cash flow from operations.
  • Each year in the past 5 years ILM1 has been profitable.
  • Of the past 5 years ILM1 4 years had a positive operating cash flow.
ILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • ILM1 has a Return On Assets (2.34%) which is in line with its industry peers.
  • ILM1 has a Return On Equity (4.25%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of ILM1 (3.73%) is worse than 60.00% of its industry peers.
  • ILM1 had an Average Return On Invested Capital over the past 3 years of 3.26%. This is below the industry average of 6.83%.
  • The 3 year average ROIC (3.26%) for ILM1 is below the current ROIC(3.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.34%
ROE 4.25%
ROIC 3.73%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ILM1.DE Yearly ROA, ROE, ROICILM1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • The Profit Margin of ILM1 (1.09%) is worse than 60.00% of its industry peers.
  • ILM1's Profit Margin has declined in the last couple of years.
  • ILM1 has a Operating Margin of 2.21%. This is amonst the worse of the industry: ILM1 underperforms 80.00% of its industry peers.
  • In the last couple of years the Operating Margin of ILM1 has declined.
  • ILM1 has a worse Gross Margin (9.66%) than 63.33% of its industry peers.
  • ILM1's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.21%
PM (TTM) 1.09%
GM 9.66%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
ILM1.DE Yearly Profit, Operating, Gross MarginsILM1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ILM1.DE Health Analysis

2.1 Basic Checks

  • ILM1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ILM1 has more shares outstanding
  • The number of shares outstanding for ILM1 has been increased compared to 5 years ago.
  • ILM1 has a worse debt/assets ratio than last year.
ILM1.DE Yearly Shares OutstandingILM1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ILM1.DE Yearly Total Debt VS Total AssetsILM1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • ILM1 has an Altman-Z score of 3.23. This indicates that ILM1 is financially healthy and has little risk of bankruptcy at the moment.
  • ILM1's Altman-Z score of 3.23 is amongst the best of the industry. ILM1 outperforms 86.67% of its industry peers.
  • ILM1 has a debt to FCF ratio of 2.17. This is a good value and a sign of high solvency as ILM1 would need 2.17 years to pay back of all of its debts.
  • The Debt to FCF ratio of ILM1 (2.17) is better than 93.33% of its industry peers.
  • ILM1 has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • ILM1 has a Debt to Equity ratio of 0.32. This is amongst the best in the industry. ILM1 outperforms 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.17
Altman-Z 3.23
ROIC/WACC0.55
WACC6.79%
ILM1.DE Yearly LT Debt VS Equity VS FCFILM1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • ILM1 has a Current Ratio of 1.74. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ILM1 (1.74) is better than 83.33% of its industry peers.
  • A Quick Ratio of 1.31 indicates that ILM1 should not have too much problems paying its short term obligations.
  • The Quick ratio of ILM1 (1.31) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.31
ILM1.DE Yearly Current Assets VS Current LiabilitesILM1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ILM1.DE Growth Analysis

3.1 Past

  • ILM1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.63%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -5.00% on average over the past years.
  • The Revenue has grown by 9.27% in the past year. This is quite good.
  • Measured over the past years, ILM1 shows a very strong growth in Revenue. The Revenue has been growing by 29.51% on average per year.
EPS 1Y (TTM)63.63%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%80.36%
Revenue 1Y (TTM)9.27%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.17% on average over the next years. This is quite good.
  • ILM1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.79% yearly.
EPS Next Y5.3%
EPS Next 2Y17.64%
EPS Next 3Y19.17%
EPS Next 5YN/A
Revenue Next Year8.39%
Revenue Next 2Y6.17%
Revenue Next 3Y5.58%
Revenue Next 5Y2.79%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ILM1.DE Yearly Revenue VS EstimatesILM1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
ILM1.DE Yearly EPS VS EstimatesILM1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. ILM1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.74, ILM1 is valued on the expensive side.
  • ILM1's Price/Earnings is on the same level as the industry average.
  • ILM1 is valuated rather cheaply when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
  • ILM1 is valuated reasonably with a Price/Forward Earnings ratio of 11.65.
  • 80.00% of the companies in the same industry are more expensive than ILM1, based on the Price/Forward Earnings ratio.
  • ILM1 is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.74
Fwd PE 11.65
ILM1.DE Price Earnings VS Forward Price EarningsILM1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ILM1 indicates a rather cheap valuation: ILM1 is cheaper than 90.00% of the companies listed in the same industry.
  • ILM1's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ILM1 is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.56
EV/EBITDA 6.23
ILM1.DE Per share dataILM1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ILM1's earnings are expected to grow with 19.17% in the coming years.
PEG (NY)3.53
PEG (5Y)N/A
EPS Next 2Y17.64%
EPS Next 3Y19.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ILM1.DE Dividend Analysis

5.1 Amount

  • ILM1 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILM1.DE Fundamentals: All Metrics, Ratios and Statistics

MEDIOS AG

FRA:ILM1 (3/4/2026, 5:29:45 PM)

16.3

+0.24 (+1.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11
Earnings (Next)03-26
Inst Owners39.25%
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap415.81M
Revenue(TTM)2.01B
Net Income(TTM)22.03M
Analysts87.27
Price Target24.48 (50.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.08%
Valuation
Industry RankSector Rank
PE 18.74
Fwd PE 11.65
P/S 0.21
P/FCF 4.56
P/OCF 4.21
P/B 0.8
P/tB 15.13
EV/EBITDA 6.23
EPS(TTM)0.87
EY5.34%
EPS(NY)1.4
Fwd EY8.59%
FCF(TTM)3.58
FCFY21.95%
OCF(TTM)3.87
OCFY23.75%
SpS78.89
BVpS20.31
TBVpS1.08
PEG (NY)3.53
PEG (5Y)N/A
Graham Number19.94
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 4.25%
ROCE 6.15%
ROIC 3.73%
ROICexc 4.29%
ROICexgc 19.24%
OM 2.21%
PM (TTM) 1.09%
GM 9.66%
FCFM 4.54%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexgc growth 3Y-0.85%
ROICexgc growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score7
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.17
Debt/EBITDA 2.04
Cap/Depr 19.67%
Cap/Sales 0.37%
Interest Coverage 3.48
Cash Conversion 119.67%
Profit Quality 414.43%
Current Ratio 1.74
Quick Ratio 1.31
Altman-Z 3.23
F-Score7
WACC6.79%
ROIC/WACC0.55
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.63%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%80.36%
EPS Next Y5.3%
EPS Next 2Y17.64%
EPS Next 3Y19.17%
EPS Next 5YN/A
Revenue 1Y (TTM)9.27%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.13%
Revenue Next Year8.39%
Revenue Next 2Y6.17%
Revenue Next 3Y5.58%
Revenue Next 5Y2.79%
EBIT growth 1Y59.29%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year99.49%
EBIT Next 3Y34.03%
EBIT Next 5Y29.68%
FCF growth 1Y229.48%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y228.59%
OCF growth 3Y6.19%
OCF growth 5YN/A

MEDIOS AG / ILM1.DE FAQ

What is the fundamental rating for ILM1 stock?

ChartMill assigns a fundamental rating of 5 / 10 to ILM1.DE.


What is the valuation status of MEDIOS AG (ILM1.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to MEDIOS AG (ILM1.DE). This can be considered as Fairly Valued.


How profitable is MEDIOS AG (ILM1.DE) stock?

MEDIOS AG (ILM1.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for ILM1 stock?

The Earnings per Share (EPS) of MEDIOS AG (ILM1.DE) is expected to grow by 5.3% in the next year.


How sustainable is the dividend of MEDIOS AG (ILM1.DE) stock?

The dividend rating of MEDIOS AG (ILM1.DE) is 0 / 10 and the dividend payout ratio is 0%.